The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known ...
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...
Separately, an IAF aircraft conducted a precision strike, targeting a Hamas terrorist in the al-Furqan neighborhood of Gaza City. Information ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...